Better substances for treating dengue virus proposed

10 diciembre 2014

Potential new active substances for treating the dengue virus are being proposed by European scientists. In the quest for medication to treat the dengue virus, the scientific community is focusing on a particular enzyme of the pathogen, the protease known as NS2B/NS3. The reason for this is that inhibitors of similar proteases have been revealed to be very effective with other viruses. Protease inhibitors are already being used successfully in the treatment of HIV and Hepatitis patients.